Report Highlights
The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.
Report Includes
- 56 data tables and 28 additional tables
- An overview of the global markets for microelectromechanical systems (MEMS) in the medical industry
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the current market size and revenue forecast for MEMS devices in global medical markets, and a corresponding market share analysis based on product, application and region
- Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and future prospects
- Discussion of sustainability trends and ESG trends in the global market, with emphasis on consumer attitudes, ESG score analysis, case studies and the ESG practices of leading companies
- Review of patents on MEMS devices in the medical industry
- An analysis of the industry structure, including company market shares, recent M&A activity and venture funding.
- Competitive intelligence related to leading companies, their global rankings, recent developments, key financials and segmental revenues, and product portfolios
- Profiles of the leading market players, including TE Connectivity, Honeywell International Inc., STMicroelectronics, Teledyne Dalsa, and Silex Microsystems
Report Scope
The current version provides an overview of the global market for MEMS medical devices. This report analyzes the market trends associated with MEMS devices using data from 2020, 2021, the base year data for 2022, estimated from 2023, with projections of compound annual growth rates (CAGRs) through 2028. The report will analyze the current market drivers, restraints, and opportunities, as well as market projections for 2028.
The products covered in this report include sensors (pressure, inertial, optical, magnetic, temperature and other sensors), drug delivery systems (inhalers/nebulizers, microneedles and micropumps), and microfluidic and lab-on-a-chip devices (clinical in vitro diagnostic, point-of-care, medical research, and analytical devices). Applications covered include in vitro diagnostics, medical devices, pharmaceutical and life sciences research, and home healthcare. The market has been segmented into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, 2022 serves as the base year; forecasts are given for 2023 through 2028.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||
| Base year market size | $4.4 billion | ||||||||||||
| Market size forecast | $7.2 billion | ||||||||||||
| Growth rate | CAGR of 8.5% for the forecast period of 2023-2028 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | Product, Application, and Geographic Region | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||
| Countries covered | U.S, Canada, France, Germany, Italy, Spain, UK, China, India, Japan, Brazil, GCC Countries, Saudi Arabia, Middle East, and South Africa | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The MEMS devices market for the medical industry increased from $1.6 billion in 2011 to $1.9 billion in 2012 and is expected to reach $5.1 billion in 2017, a compound annual growth rate (CAGR) of 22.0% for the forecast period of 2012 to 2017.
Report Includes
- An overview of the use of microelectromechanical systems (MEMS) in global medical markets
- Analyses of global market trends, with historical data from 2010, 2011, and 2012, and projections of compound annual growth rates (CAGRs) through 2017
- A breakdown of market definition and technology growth, market dynamics, drivers, restraints, opportunities and challenges, and the competitive environment
- Market segmentation by products, including pressure sensors, accelerometers, flow sensors, microphones, drug-delivery devices, gyroscopes, and lab-on-a-chip
- Discussion of research applications, diagnostics, home healthcare, and therapeutic/medical devices
- Comprehensive company profiles of key players in the industry.
Related Reports
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Drug Discovery Technologies
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
Sensors: Technologies and Global Markets
The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More